ArticleExperimental & molecular medicine2020

Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1.

Hye-Kyung Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.